Cellectar Biosciences (NV40) Ownership - Who Owns Cellectar Biosciences?
Cellectar Biosciences (NV40) Ownership Overview
- 0.97% Insiders
- 4.11% Mutual Funds
- 23.18% Other Institutional Investors
- 3.29% ETFs
- 68.45% Public Companies and Individual Investors
The ownership structure of Cellectar Biosciences (DE:NV40) stock is a mix of institutional, retail, and individual investors. Approximately 30.58% of the company’s stock is owned by Institutional Investors, 0.97% is owned by Insiders, and 68.45% is owned by Public Companies and Individual Investors.
The ownership structure of Cellectar Biosciences (DE:NV40) stock is a mix of institutional, retail, and individual investors. Approximately 30.58% of the company’s stock is owned by Institutional Investors, 0.97% is owned by Insiders, and 68.45% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 10, 2026 | Jarrod Longcor | $24,998 | |
| May 10, 2026 | James V Caruso | $24,998 | |
| Dec 15, 2025 | John Neis | $731 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 327,367 | Institution | 3.46% | 105,412 |
| Vanguard | 310,898 | Institution | 3.29% | 100,109 |
| Fidelity Concord Street Trust | 61,131 | Institution | 0.65% | 19,684 |
| Douglas Swirsky | 25,000 | Insider | 0.26% | 8,050 |
| Jarrod Longcor | 20,451 | Insider | 0.22% | 6,585 |
| James V Caruso | 20,318 | Insider | 0.21% | 6,542 |
| Frederick Driscoll | 19,417 | Insider | 0.21% | 6,252 |
| Chad J Kolean | 6,418 | Insider | 0.07% | 2,067 |
| John Neis | 10 | Insider | <0.01% | 3 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 327,367 | Institution | 3.46% | 105,412 |
| Fidelity Concord Street Trust | 61,131 | Institution | 0.65% | 19,684 |
FAQ
Who Owns Cellectar Biosciences (DE:NV40)?
According to the latest TipRanks data, approximately 30.58% of the company's stock is held by institutional investors, 0.97% is held by insiders, and 68.45% is held by public companies and individual investors.
What percentage of Cellectar Biosciences (DE:NV40) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.58% of Cellectar Biosciences (DE:NV40) stock is held by institutional investors: 4.11% by mutual funds, 3.29% by ETFs and 23.18% by other institutional investors.
What percentage of Cellectar Biosciences (DE:NV40) stock is held by retail investors?
According to the latest TipRanks data, approximately 68.45% of Cellectar Biosciences (DE:NV40) stock is held by public companies and individual investors.
Who owns the most shares of Cellectar Biosciences (DE:NV40)?
VANGUARD INDEX FUNDS owns the most shares of Cellectar Biosciences (DE:NV40).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.